Skip to main content

Receive our email newsletter

Register your details below to receive our regular email newsletter, along with digital copies of Speciality Chemicals Magazine.

Current Issue

Steve Klosk
Permira buys Cambrex
Cambrex has signed a definitive agreement to be acquired by an affiliate of private equity firm Permira, which has $48 billion of committed capital in its portfolio, covering healthcare among four other sectors.
Clariant CEO leaves as Sabic deal suspended
Clariant and Sabic have agreed to temporarily suspend the discussions on combining the former’s Additives business, the high value part of the Masterbatches business and parts of the latter’s Specialties business into a single ‘High Performance Materials’ business area.
Brenntag acquires in Africa and Taiwan
Chemical distribution giant Brenntag has initiated or completed four acquisitions within the space of a few days. The company has agreed to acquire the 50% stake it did not already have in Crest Chemicals in South Africa, the operating business of Chemgrit Cosmetics.
Onyx plans commercial API manufacture
Onyx Scientific has revealed that it has been engaging with the UK Medicines & Healthcare Products Regulatory Agency (MHRA) with a view to securing a commercial API licence by the end of 2019.